| 603 |
Triclosan
|
-
Triclosan, CAS-RN: 3380-34-5, DTXSID5032498
|
2 AOPs
|
| 54 |
Trimethyltin chloride
|
-
Trimethyltin chloride, CAS-RN: 1066-45-1, DTXSID6042496
|
None
|
| 548 |
Triphenyl phosphate
|
-
Triphenyl phosphate, CAS-RN: 115-86-6, DTXSID1021952
|
2 AOPs
|
| 379 |
Tris(1,3-dichloropropyl)phosphate - TDCPP
|
-
Tris(1,3-dichloro-2-propyl) phosphate, CAS-RN: 13674-87-8, DTXSID9026261
|
None
|
| 557 |
Triticonazole
|
-
Triticonazole, CAS-RN: 131983-72-7, DTXSID0032655
|
None
|
| 70 |
Troglitazone
|
-
Troglitazone, CAS-RN: 97322-87-7, DTXSID8023719
|
163: PPARgamma activation leading to sarcomas in rats, mice, and hamsters
|
| 416 |
Tunicamycin
|
-
Tunicamycin, CAS-RN: 11089-65-9, DTXSID8036730
|
None
|
| 477 |
TWS119
|
-
TWS119, CAS-RN: 601514-19-6, DTXSID00429550
|
None
|
| 123 |
Tylenol
|
|
None
|
| 274 |
Ultraviolet B radiation
|
|
9 AOPs
|
| 629 |
unmethylated CpG motifs (DNA;RNA;ODN)
|
|
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|
| 664 |
Uranium
|
-
Uranium, CAS-RN: 7440-61-1, DTXSID1042522
|
2 AOPs
|
| 738 |
Uranium, soluble salts
|
-
Uranium, soluble salts, CAS-RN: NOCAS, DTXSID7024374
|
447: Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways
|
| 539 |
Urethane
|
-
Urethane, CAS-RN: 51-79-6, DTXSID9021427
|
None
|
| 253 |
UV-activated Titanium dioxide nanoparticles
|
|
208: Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure
|
| 784 |
UV-B and UV-C
|
|
550: Increased LMNA gene mutation leading to heart failure
|
| 97 |
Valproate
|
|
212: Histone deacetylase inhibition leading to testicular atrophy
|
| 401 |
Valproic acid
|
-
Valproic acid, CAS-RN: 99-66-1, DTXSID6023733
|
274: Histone deacetylase inhibition leads to impeded craniofacial development
|
| 330 |
Vancomycin
|
-
Vancomycin, CAS-RN: 1404-90-6, DTXSID0042664
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 55 |
Vatalanib
|
-
Vatalanib, CAS-RN: 212141-54-3, DTXSID2046919
-
Sunitinib malate, CAS-RN: 341031-54-7, DTXSID4046492
|
43: Disruption of VEGFR Signaling Leading to Developmental Defects
|
| 118 |
Verapamil
|
-
(+/-)-Verapamil, CAS-RN: 52-53-9, DTXSID9041152
|
2 AOPs
|
| 686 |
Vernolate
|
-
Vernolate, CAS-RN: 1929-77-7, DTXSID7024376
|
None
|
| 469 |
Vinblastine sulfate
|
-
Vinrosidine sulfate (1:x), CAS-RN: 18556-44-0, DTXSID7047853
|
106: Chemical binding to tubulin in oocytes leading to aneuploid offspring
|
| 136 |
Vinclozalin
|
|
None
|
| 556 |
Vinclozolin
|
-
Vinclozolin, CAS-RN: 50471-44-8, DTXSID4022361
|
3 AOPs
|